ContextVision shows strong momentum in Q4, leading to record sales for the year

ContextVision, Financial reports, Home, Investor News, News 2022-02-17
STOCKHOLM – Feb 16, 2022- ContextVision, a medical technology software company specializing in image processing, image analysis and decision support tools for digital pathology, today reports its fourth quarter and full year 2021 results. Total sales 2021 reached 98.1 MSEK (94.7), which is the highest revenue in the history of the company. After a slow […]
Read More

ContextVision Announces New Leadership Team, Appoints Ola Lindblad as CEO

ContextVision, Home, News 2022-02-14
STOCKHOLM – February 14, 2022 – ContextVision, a medical technology software company specializing in image quality and artificial intelligence, announces a new executive leadership team following the spin out of the company’s digital pathology arm into a new standalone business. Previous leaders at ContextVision will assume new roles, including the appointment of Ola Lindblad as […]
Read More

ContextVision – Information regarding dividend and reverse share split in Inify Laboratories

ContextVision, Digital Pathology, Home, Investor News, News 2022-02-11
ContextVision AB (“ContextVision” or the “Company”) will, in accordance with the press release published on 2 February 2022, distribute all shares in its wholly-owned subsidiary INIFY Laboratories AB (“INIFY”) to the shareholders of ContextVision. The shares in INIFY are expected to be delivered to shareholders who have their shares registered at Euroclear Sweden AB around […]
Read More

ContextVision announces resolution regarding record date for dividend

ContextVision, Digital Pathology, Home, Investor News, News 2022-02-02
Stockholm, February 2nd, at the extraordinary general meeting in ContextVision AB (“ContextVision” or the “Company”) held on 10 December 2021 the meeting resolved to distribute all shares in the wholly-owned company INIFY Laboratories AB, company registration number 559345-4431 (“INIFY”) to the shareholders of the Company. The board of directors has determined the record date for […]
Read More

ContextVision – new CFO appointed

ContextVision, Home, Investor News, News 2022-01-20
Stockholm, January 12th, 2022 – ContextVision, the world’s leading Image enhancement provider is pleased to announce the appointment of Markus Hökerberg as an interim Chief Financial Officer, effective 25th of January. He succeeds Ann-Charlotte Linderoth, who will take on the same role at Inify Laboratories, a spinoff from ContextVision. Mrs Linderoth will remain within the […]
Read More

INIFY Laboratories AB becomes an independent company

ContextVision, Export, Home, Investor News, News 2021-12-10
STOCKHOLM – December 10, 2021 – ContextVision, a medical technology software company specializing in image processing, today announces that at the EGM of ContextVision on Dec 10th, it was resolved that the subsidiary INIFY Laboratories will become an independent company through a distribution of its shares to existing shareholders of ContextVision. The company will build […]
Read More

ContextVision Extraordinary General Meeting

ContextVision, Home, Investor News, News 2021-12-10
On the 10th of December 2021, ContextVision AB held an Extraordinary General Meeting in Stockholm. The Board’s proposal for a resolution on dividend of all shares in the Company’s wholly-owned subsidiary INIFY Laboratories AB containing the line of business Digital Pathology to the shareholders of ContextVision AB, was approved. No other matters were processed at […]
Read More

Notice to extraordinary general meeting in ContextVision AB (Publ)

ContextVision, Home, Investor News, News 2021-11-15
The shareholders of ContextVision AB, corporate registration number 556377-8900, are hereby invited to attend an extraordinary general meeting on the 10 December, 2021 at 10 a.m CET at ContextVision AB’s office, Klara Norra Kyrkogata 31, 111 22, Stockholm. Right to participate and notification Shareholders who wish to participate in the annual general meeting with the […]
Read More